Sucampo has a constipation drug Amitiza on the market and several rare disease treatments in its pipeline, which Mallinckrodt hopes can offset the decline of its biggest seller, Acthar.

The Ireland-domiciled company was accused of illegally paying smaller drug rebates to Medicaid than were due, as well as using a charitable foundation to cover co-pays for its Acthar Gel ...